Neutrophil-to-lymphocyte ratio (nlr) and platelet-to-lymphocyte ratio (plr) as predictive biomarkers of pathologic complete response (pcr) in neoadjuvant breast cancer: an irish clinical oncology group study (icorg 16-20)
View/ Open
Full Text
Date
2016-10-01Author
Rafee, S.
McHugh, D.J.
Greally, M.
Ayodele, O.
Keegan, N.
Lim, M.
Hassan, A.
O'Mahony, D.
Hennessy, B.
Kelly, C.
Kennedy, J.
Walshe, J.
O'Connor, M.
Leonard, G.
Murphy, V.
Livingstone, V.
Corrigan, M.
O'Reilly, S.
Metadata
Show full item recordUsage
This item's downloads: 0 (view details)
Recommended Citation
Rafee, S. McHugh, D.J.; Greally, M.; Ayodele, O.; Keegan, N.; Lim, M.; Hassan, A.; O'Mahony, D.; Hennessy, B.; Kelly, C.; Kennedy, J.; Walshe, J.; O'Connor, M.; Leonard, G.; Murphy, V.; Livingstone, V.; Corrigan, M.; O'Reilly, S. (2016). Neutrophil-to-lymphocyte ratio (nlr) and platelet-to-lymphocyte ratio (plr) as predictive biomarkers of pathologic complete response (pcr) in neoadjuvant breast cancer: an irish clinical oncology group study (icorg 16-20). Annals of Oncology 27 ,